HEALTHY EXTRACTS INC. (HYEX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2.5M 5M 7.5M Q3 '16: 167.9K Q4 '16: 162.8K Q1 '17: 165.8K Q2 '17: 162K Q3 '17: 154K Q4 '17: 128.1K Q1 '18: 106K Q2 '18: 99.5K Q3 '18: 80.2K Q4 '18: 67.1K Q1 '19: 144.5K Q2 '19: 314.5K Q3 '19: 572.6K Q4 '19: 748.4K Q1 '20: 802.8K Q2 '20: 753.5K Q3 '20: 1M Q4 '20: 976K Q1 '21: 1M Q2 '21: 1.1M Q3 '21: 1M Q4 '21: 1.7M Q1 '22: 2.1M Q2 '22: 2.2M Q3 '22: 2.3M Q4 '22: 2.3M Q1 '23: 2.4M Q2 '23: 2.5M Q3 '23: 2.6M Q4 '23: 2.5M Q1 '24: 2.6M Q2 '24: 2.9M Q3 '24: 3M Q4 '24: 3.1M Q1 '25: 3.4M Q2 '25: 3.4M Q3 '25: 3.6M Q4 '25: 4.5M Q1 '26: 5.2M Q2 '26: 6.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 1.5M 3M 4.5M Q4 '21: 695.1K Q1 '22: 890.8K Q2 '22: 954.9K Q3 '22: 1.1M Q4 '22: 1.4M Q1 '23: 1.3M Q2 '23: 1.3M Q3 '23: 1.4M Q4 '23: 1.6M Q1 '24: 1.8M Q2 '24: 2M Q3 '24: 2.1M Q4 '24: 1.9M Q1 '25: 1.9M Q2 '25: 2M Q3 '25: 1.9M Q4 '25: 2.4M Q1 '26: 3M Q2 '26: 3.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-9M -6M -3M 0 3M 6M 9M Q3 '16: -1.7M Q4 '16: -3.4M Q1 '17: -3.5M Q2 '17: -3.6M Q3 '17: -4.2M Q4 '17: -3.6M Q1 '18: -3.1M Q2 '18: -3.4M Q3 '18: -2.6M Q4 '18: -3.3M Q1 '19: -1.7M Q2 '19: -1.6M Q3 '19: -1.4M Q4 '19: 632.8K Q1 '20: -4.3M Q2 '20: -7.5M Q3 '20: -5M Q4 '20: -6.6M Q1 '21: -4.5M Q2 '21: -1.7M Q3 '21: -4.2M Q4 '21: -2M Q1 '22: -690.5K Q2 '22: -992K Q3 '22: -489.8K Q4 '22: -983.1K Q1 '23: -1.6M Q2 '23: -2M Q3 '23: -2.1M Q4 '23: -2.5M Q1 '24: -2.8M Q2 '24: -1.4M Q3 '24: -771.9K Q4 '24: -840.2K Q1 '25: -377.8K Q2 '25: -424.2K Q3 '25: -1.2M Q4 '25: -881.1K Q1 '26: -682.9K Q2 '26: -879.4K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 900K 1.8M 2.7M Q1 '16: 58.2K Q2 '16: 57K Q3 '16: 24.1K Q4 '16: 26.9K Q1 '17: 18.3K Q2 '17: 33K Q3 '17: 39.8K Q4 '18: 28.6K Q1 '19: 45.7K Q2 '19: 81K Q3 '19: 97.7K Q4 '19: 524.5K Q1 '20: 513.3K Q2 '20: 487.7K Q3 '20: 698.3K Q4 '20: 1.7M Q1 '21: 1.7M Q2 '21: 1.7M Q3 '21: 1.6M Q4 '21: 557K Q1 '22: 742.5K Q2 '22: 904.3K Q3 '22: 900.6K Q4 '22: 968.2K Q1 '23: 1.1M Q2 '23: 1.2M Q3 '23: 1.2M Q4 '23: 864.1K Q1 '24: 807.4K Q2 '24: 926.3K Q3 '24: 948.4K Q4 '24: 1.2M Q1 '25: 1.4M Q2 '25: 1.4M Q3 '25: 1.7M Q4 '25: 2.1M Q1 '26: 2.2M Q2 '26: 2.4M Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-3M -1.5M 0 1.5M 3M 4.5M Q4 '15: -497.8K Q1 '16: -567.6K Q2 '16: -550K Q3 '16: -529.8K Q4 '16: -537.1K Q1 '17: -659.7K Q2 '17: -716.9K Q3 '17: -611.5K Q4 '17: -672.2K Q1 '18: -635.2K Q2 '18: -619.1K Q3 '18: -578.5K Q4 '18: -328.8K Q1 '19: -2.3M Q2 '19: -2.2M Q3 '19: -3M Q4 '19: -1.7M Q1 '20: 270.3K Q2 '20: -1.4M Q3 '20: -1.7M Q4 '20: -1.9M Q1 '21: -2.4M Q2 '21: -726.7K Q3 '21: 43.9K Q4 '21: -901.3K Q1 '22: -374.4K Q2 '22: -389.7K Q3 '22: -202.8K Q4 '22: -390.6K Q1 '23: -625.1K Q2 '23: -636.8K Q3 '23: -618.3K Q4 '23: -415.7K Q1 '24: -54.1K Q2 '24: 175.6K Q3 '24: 295.7K Q4 '24: 282K Q1 '25: 323.3K Q2 '25: 171.4K Q3 '25: -160.8K Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Free Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q4 '19: -1.8M Q4 '21: -901.3K Q1 '22: -382.4K Q2 '22: -397.7K Q3 '22: -210.8K Q4 '22: -398.6K Q1 '23: -625.1K Q2 '23: -636.8K Q3 '23: -618.3K Q4 '23: -415.7K Q1 '24: -54.1K Q2 '24: 175.6K Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '23 Q2 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q4 '15: -0.06 Q1 '16: -0.08 Q2 '16: -0.08 Q3 '16: -0.12 Q4 '16: -0.21 Q1 '17: -0.22 Q2 '17: -1.59 Q3 '17: -13.16 Q4 '17: -15.82 Q1 '18: -15.79 Q2 '18: -14.62 Q3 '18: -3.39 Q4 '18: -1.09 Q1 '19: -1.07 Q2 '19: -0.86 Q3 '19: -0.47 Q4 '19: 0.01 Q1 '20: -0.03 Q2 '20: -0.05 Q3 '20: -0.03 Q4 '20: -0.01 Q1 '21: 0.01 Q2 '21: 0.03 Q3 '21: 0.02 Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20 Q3 '21

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.